PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmaceutical Biotechnology, Eberhard Karls University, Tübingen, Germany.\', \'NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.\', \'Institute of Virology, Medical Center University Freiburg, Freiburg, Germany.\', \'Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.\', \'Institute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.\', \'Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies\', Eberhard Karls University, Tübingen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.15252/embr.202153865
?:hasPublicationType
?:journal
  • EMBO reports
is ?:pmid of
?:pmid
?:pmid
  • 34927793
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.724
?:rankingScore_hIndex
  • 158
?:title
  • Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34927793>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34927793>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all